Stock ANNX ANNEXON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Annexon, Inc.

Equities

ANNX

US03589W1027

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-11 pm EDT 		5-day change 1st Jan Change
5.46 USD -4.55% Intraday chart for Annexon, Inc. -8.85% +20.26%
Jun. 06 Sector Update: Health Care Stocks Steady Premarket Thursday MT
Jun. 06 Annexon Prices $125 Million Stock Offering MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Annexon : Topline Results from Phase 3 Study of ANX005 in Guillain-Barré Syndrome
PU
Sector Update: Health Care Stocks Steady Premarket Thursday
MT
Annexon Prices $125 Million Stock Offering
MT
Annexon Announces Pricing of $125 Million Underwritten Public Offering
GL
Sector Update: Health Care Stocks Steady Premarket Wednesday
MT
ANNEXON ANNOUNCES POSITIVE TOPLINE RESULTS FROM PIVOTAL PHASE 3 TRIAL FOR FIRST-IN-CLASS C1Q BLOCKING ANTIBODY ANX005 IN GUILLAIN-BARRE SYNDROME
AQ
Annexon Launches $125 Million Share Offering
MT
Annexon Announces Proposed Public Offering of Common Stock
GL
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday
MT
Traders on Edge Amid Signs of Weaker Economic Growth, Stifling US Equity Futures Pre-Bell
MT
Sector Update: Health Care
MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Weak Economic Data Adds to Interest Rate Cut Pessimism
MT
Annexon : GBS Program Update Presentation
PU
Transcript : Annexon, Inc. - Special Call
Annexon Says Phase 3 Trial of Potential Guillain-Barre Syndrome Treatment Meets Primary Endpoint
MT
Top Premarket Gainers
MT
Annexon's neurological disorder drug meets main goal of late-stage study
RE
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
GL
Annexon, Inc. Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
CI
North American Morning Briefing : Weak Data Hold Back Stocks
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ANNX Stock
  4. News Annexon, Inc.